Stockreport

CytomX Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com
PDF Net loss: US$569.0k (loss narrowed by 99% from FY 2022). US$0.008 loss per share (improved from US$1.51 loss in FY 2022). CTMX Products In Clinical Trials Phase I [Read more]